Quantcast Cold Antibodies - Immunohematology and Blood Banking II

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
(2)  Variation in the strength of the antigen. Some antigens that do not show
dosage in terms of zygosity may vary in strength on cells from different individuals. The
antigens most notable for this are P1, Sda, Lea, Leb, and I. Sometimes diminished
antigenic strength can be related to disease, or to the length of time that the cell
suspension has been stored.
1-38. COLD ANTIBODIES
a. Background. These antibodies react best at room temperature (RT) and
below, while reactions after 37C incubation and with AGT are negative or weakly
positive. Some cold agglutinating antibodies, notably anti-I, anti-lH, and anti-H, bind
complement following the antigen-antibody interaction at low temperatures; subsequent
37C incubation may cause the antibody to elute from the cell, but the attached
complement remains, and produces a positive reaction when antiglobulin serum is
added. An antibody displaying these characteristics in the screening test or in
crossmatches should be tested at 18C and/or 4C with specially selected cells, such as
cord cells.
b. Cold Autoabsorption to Remove Cold-Reactive Autoantibody.
(1)  When a strong, cold, autoantibody is present, meaningful
antibody-screening and compatibility studies cannot be done until the autoantibody is
removed. This can be done with the patient's untreated or enzyme-treated cells.
Enzyme pretreatment results in faster antibody removal, and is more effective with very
high-titered autoantibodies. Untreated autoabsorption is usually satisfactory for
removing low-level activity.
(2)  Some alloantibody may also be removed by the Matuhasi-Ogata
phenomenon, or by transfused cells in the circulation. In recently transfused patients,
when autoabsorption might result in removing alloantibody activity, the
antibody-screening test and compatibility tests should be done at 37C, using serum
from a blood sample clotted at 37C and kept at that temperature until the serum is
removed. This permits detection of antibodies active at 37C, and by AGT, but not
cold-reactive alloantibodies.
(a) STEP 1. Obtain a blood specimen from the patient. At the bedside
draw two specimens of blood, one in a tube immediately placed in ice, the other in a
tube containing anticoagulant and incubate it at once at 37C. To do this, bring a
heated block, water bath, or vacuum jug of 37C water to the patient's bedside. The
tube may also be transported in an inside pocket.
(b) STEP 2. Allow the first (iced) specimen to clot in the refrigerator.
Separate the serum by centrifuging in ice-filled cups or a refrigerated centrifuge.
Immediately remove the serum from the clot.
MD0846
1-52



Medical News
A Quarter of Uninsured Say They Can’t Afford to Buy Coverage
(MedPage Today) -- It's the most common reason given for...
medpagetoday.com
Ebola: Can It End Next Summer?
(MedPage Today) -- U.N. Secretary-General says West Africa epidemic will...
medpagetoday.com
Grand Roundup: Top posts for week of Nov. 16
The five most-read stories this week on Scope were: My...
scopeblog.stanford.edu
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This weeks topics include manual versus mechanical...
medpagetoday.com
D.C. Week: House Sues Over ACA; Generic Drug Prices Scrutinized
(MedPage Today) -- Boehner makes good on lawsuit threat....
medpagetoday.com
Mali announces new Ebola case
Mali announced Saturday a new case of Ebola in a...
medicalxpress.com
Plague outbreak kills 40 in Madagascar: WHO
An outbreak of plague has killed 40 people in Madagascar,...
medicalxpress.com
Dutch cull ducks amid bird flu fears in poultry heartland
The Dutch authorities on Saturday ordered the preventative cull of...
medicalxpress.com
Boob Glue, Spilt Beer: That's Improbable!
(MedPage Today) -- A weekly report from our friends over...
medpagetoday.com
Hope in Liberia, anxiety in Mali as Ebola battle rages
Liberia has set itself the target of halting Ebola by...
medicalxpress.com
Structured education program beneficial for anaphylaxis
(HealthDay)—A structured education intervention improves knowledge and emergency management for...
medicalxpress.com
Prosocial internet support group not beneficial for breast cancer
(HealthDay)—A prosocial Internet support group (ISG) that encourages breast cancer...
medicalxpress.com
Review: Ketogenic diets suppress appetite despite weight loss
(HealthDay)—A review of evidence supports that ketogenic diets suppress appetite...
medicalxpress.com
Feds vows to publicize vaccine injury help program
Leaders of the nation's system for helping people injured by...
medicalxpress.com
Testosterone testing has increased in recent years
(HealthDay)—There has been a recent increase in the rate of...
medicalxpress.com
UN chief: Ebola cases in Mali a 'deep concern'
The United Nations chief warned Friday that Ebola may be...
medicalxpress.com
Ebola returns to city at Sierra Leone outbreak epicentre
Sierra Leone announced a death from Ebola on Friday in...
medicalxpress.com
Switzerland bans Dutch poultry imports, new bird flu cases in Holland
Switzerland on Friday said it was banning chicken imports from...
medicalxpress.com
AMA: Gender inequality still exists in medicine
(HealthDay)—Gender inequality still exists in medicine, according to an article...
medicalxpress.com
Doubling saturated fat in the diet does not increase saturated fat in blood, study finds
Doubling or even nearly tripling saturated fat in the diet...
medicalxpress.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +